ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,526,728, issued on Jan. 13, was assigned to Amgen Inc. (Thousand Oaks, Calif.).
"Processes for preparing a MDM2 inhibitor" was invented by Sebastien Caille (Thousand Oaks, Calif.), Michael Corbett (Thousand Oaks, Calif.) and Austin Smith (Thousand Oaks, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides commercial processes for preparing 2-((3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-((S)-1-(isopropylsulfonyl)-3-methylbutan-2-yl)-3-methyl-2-oxopiperidin-3-yl)acetic acid as well as intermediates thereof."
The patent was filed on Aug. 1, 2023, under Application No. 18/363,661.
*For further information, including ...